A company that truly wanted to get involved would be far
A company that truly wanted to get involved would be far smarter to partner with OWCP and take a solid ownership position with a substantial cash infusion into the company. With 20% or more they should get a seat on the board and frankly would make more than if they acquired the company as they worked to build the share price. They could see their shares rise thousands of percentage points in building the company which could be worth more than if they acquired it.
At some point in the future they could easily acquire it as an alliance with major institutions who would own major portions of the company by then could easily force an agreement to buy it out. They could then spin it off maintaining a majority interest, just as Roche did with Genentech a few times, and could do again.
Such a partnership would immediately have the share price well over a dollar and the company would have funding sufficient to operate for years and expand both staff and their trial efforts. I believe this is the sort of thing we may see, not a buyout.
Gary
1
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
Top 5 Most Recently Viewed Articles
Newmark Group Secures $690 Million for West Shore Portfolio Newmark Group, Inc. (NASDAQ: NMRK), a prominent name in commercial real estate advisory, has successfully arranged a substantial $690 million loan aimed at refinancing a diverse collection of 13 multifamily properties owned by West Shore. These properties are located in several states, including vibrant areas...
Continue Reading
MassageLuXe Expands Its Relaxation Services in Grand Rapids MassageLuXe, a leading spa franchise known for its exceptional massage, facial, and waxing services, is gearing up to enhance wellness offerings in the Grand Rapids area. This strategic initiative marks the company's intent to further establish its footprint in Michigan's second-largest city, driven by the...
Continue Reading
Taylor Heise Joins Upper Deck's Elite Team of Athletes Leading the charge in the realm of sports collectibles, Upper Deck recently announced an exciting partnership with Taylor Heise, a standout player in the Professional Women's Hockey League (PWHL). This collaboration highlights the growing prominence of women athletes in sports collectibles, specifically with Heise,...
Continue Reading
Eminent Gold Welcomes Ivan Bebek as Strategic Advisor Eminent Gold Corp. (TSXV: EMNT) (OTCQB: EMGDF) is making headlines with the recent appointment of Ivan Bebek as a Strategic Advisor for Corporate Development and Finance. This strategic move aims to bolster the company's efforts in identifying and advancing new gold discoveries in Nevada. Ivan Bebek: A Wealth of...
Continue Reading
Understanding B. Riley Financial's Nasdaq Situation B. Riley Financial, Inc. (Nasdaq: RILY) has announced a significant event regarding its listing status on the Nasdaq exchange. The company received a Staff Determination Letter from the Nasdaq Listing Qualifications Staff, pointing out non-compliance issues that date back to earlier notifications. These notifications...
Continue Reading